Scientific basis for PEP rests in animal trials.
D000225:Adenine / Q000627:therapeutic use*; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D006282:Health Personnel; D006801:Humans; D008251:Macaca; D019829:Nevirapine; D009784:Occupational Diseases / Q000188:drug therapy / Q000517:prevention & control; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D002679:Pan troglodytes; D011725:Pyridines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D015302:Simian Immunodeficiency Virus / Q000187:drug effects*; D000068698:Tenofovir; D014481:United States; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine; D000068698:Tenofovir; D000225:Adenine